| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 07/07/2005 | CA2792483A1 Hiv protease inhibiting sulfonamides |
| 07/07/2005 | CA2550843A1 Novel phenylalanine derivatives |
| 07/07/2005 | CA2550643A1 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof |
| 07/07/2005 | CA2550485A1 Polymorphic form b2 of ziprasidone base |
| 07/07/2005 | CA2550257A1 1-akan-2-ol substituted piperazine and piperidine compounds |
| 07/07/2005 | CA2549955A1 Heterocyclic derivatives as gpcr receptor agonists |
| 07/07/2005 | CA2549651A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 07/07/2005 | CA2549389A1 Hiv protease inhibiting sulfonamides |
| 07/07/2005 | CA2548518A1 Biaryl sulfonamides as mmp inhibitors |
| 07/06/2005 | EP1550913A1 Organophotoreceptor with charge transport material having a thiiranyl group |
| 07/06/2005 | EP1550661A1 Thiadiazole compound and use thereof |
| 07/06/2005 | EP1550657A1 Amine compounds and use thereof |
| 07/06/2005 | EP1549655A2 Substituted bicyclic thiophene derivatives, compostions containing such compounds and methods of use |
| 07/06/2005 | EP1549645A1 4,6-diaminosubstituted-2-[oxy or aminoxy]-[1,3,5]triazines as protein tyrosine kinase inhibitors |
| 07/06/2005 | EP1549644A1 Azolidinone-vinyl fused-benzene derivatives |
| 07/06/2005 | EP1549641A1 Antimicrobial 3.1.0 bicyclic oxazolidinone derivatives |
| 07/06/2005 | EP1549639A1 Sulphonamide derivatives as antipsychotic agents |
| 07/06/2005 | EP1549638A1 Indole-3-carboxamides as glucokinase (gk) activators |
| 07/06/2005 | EP1549636A1 Imidazol-1-ylmethyl pyridazine derivatives |
| 07/06/2005 | EP1549634A1 Novel substituted indoles |
| 07/06/2005 | EP1549632A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 07/06/2005 | EP1549624A2 Inhibitors of fatty acid amide hydrolase |
| 07/06/2005 | EP1549620A1 Indazolecarboxamide derivatives, preparation and use thereof as cdk1, cdk2 and cdk4 inhibitors |
| 07/06/2005 | EP1549600A1 Ketones |
| 07/06/2005 | EP1549278A2 M sb 3 /sb MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS |
| 07/06/2005 | EP1373256B1 Ccr5 antagonists useful for treating aids |
| 07/06/2005 | EP1212320B1 Phenylpiperazines as serotonin reuptake inhibitors |
| 07/06/2005 | EP1140909B1 Novel inhibitors of farnesyl-protein transferase |
| 07/06/2005 | EP1044001B1 Integrin receptor antagonists |
| 07/06/2005 | CN1636154A Di-substituted iminoheterocyclic compounds |
| 07/06/2005 | CN1636006A Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors |
| 07/06/2005 | CN1636005A Benzothiazinone and benzoxazinone compounds |
| 07/06/2005 | CN1636001A 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators |
| 07/06/2005 | CN1635892A Ziprasidone composition and synthetic controls |
| 07/06/2005 | CN1635891A Tetrahydroquinoline analogues as muscarinic agonists |
| 07/06/2005 | CN1209678C Silver halide photographic emulsion contg. methylidyne compound, and photographic material using said emulsion |
| 07/06/2005 | CN1209362C Tetrazolyl-phenyl acetamide glucokinase activators |
| 07/06/2005 | CN1209361C Hydantoin-containing glucokinase activators |
| 07/06/2005 | CN1209360C 16-halogen-epothilone derivatives, process for producing them and their pharmaceutical use |
| 07/06/2005 | CN1209016C Fungicides |
| 07/05/2005 | US6914062 Pyrazinone derivatives |
| 07/05/2005 | US6914058 1-(p-(thiomorpholino)phenyl)-1,2,3-triazole derivatives |
| 07/05/2005 | CA2183972C Oxazolidinone derivatives and pharmaceutical compositions containing them |
| 07/05/2005 | CA2072541C Heterocyclic compounds, their production and use |
| 06/30/2005 | WO2005059107A2 Chemokine receptor binding compounds |
| 06/30/2005 | WO2005058887A1 Novel thiazole derivates |
| 06/30/2005 | WO2005058886A1 Novel oxazolidinone derivatives |
| 06/30/2005 | WO2005058885A2 Piperidine derivatives and their use as glycine transporter inhibitors |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058883A1 2, 6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists |
| 06/30/2005 | WO2005058873A1 Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| 06/30/2005 | WO2005058857A1 Tetronic and tetramic acids as inhibitors of beta-secrease |
| 06/30/2005 | WO2005058848A1 (3,4-disubstituted)propanoic carboxylates as s1p (edg) receptor agonists |
| 06/30/2005 | WO2005058841A2 Hiv protease inhibiting compounds |
| 06/30/2005 | WO2005058837A1 Benzazepine derivatives as histamine h3 antagonists |
| 06/30/2005 | WO2005058836A1 Insecticidal spiroindane derivatives |
| 06/30/2005 | WO2005058834A2 Quinolines useful in treating cardiovascular disease |
| 06/30/2005 | WO2005058833A1 2-pyridinylethylcarboxamide derivatives and their use as fungicides |
| 06/30/2005 | WO2005058830A1 Novel herbicides |
| 06/30/2005 | WO2005058827A1 Process for the synthesis of pioglitazone hydrogen chloride |
| 06/30/2005 | WO2005058823A1 Urea derivative, process for producing the same, and use |
| 06/30/2005 | WO2005058822A1 Substituted amino-cycloalkanes |
| 06/30/2005 | WO2005058821A1 Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 06/30/2005 | WO2005058820A1 A synthetic methodology for the reductive alkylation at the c-3 position of indoles |
| 06/30/2005 | WO2005058813A2 Thiodiazolidinedione, oxazolidinedione and diazolidinedione derivatives and their use as antidiabetic agents |
| 06/30/2005 | WO2005058311A1 Heterocyclic aspartyl protease inhibitors |
| 06/30/2005 | WO2005058035A1 Use of (3-(1-(3-phenyl-propenyl)-piperidin-4-yl)-2,3-dihydro-indol-1-yl)-(pyridin-4-yl)-methanone derivatives and related compounds as insecticides |
| 06/30/2005 | WO2005033099A3 Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof |
| 06/30/2005 | WO2005032493A8 Amide compounds as ion channel ligands and uses thereof |
| 06/30/2005 | WO2005000852A3 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent |
| 06/30/2005 | WO2004085388A3 Cyclic protein tyrosine kinase inhibitors |
| 06/30/2005 | WO2002058698A8 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 06/30/2005 | US20050143438 N3 alkylated benzimidazole derivatives as MEk inhibitors |
| 06/30/2005 | US20050143436 N-acylamino with fused nitrogen heterocyclic ring compound; capase enzyme inhibitors; antiinflammatory agents; oral bioavailability; autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases |
| 06/30/2005 | US20050143429 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 06/30/2005 | US20050143427 treating bone disorders of joint cartilage damage, osteoarthritis, rheumatoid arthritis, or joint inflammation, and pain associate with; antiinflammatory agent; 1-methyl-octahydroindole-2-carboxylic acid |
| 06/30/2005 | US20050143422 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 06/30/2005 | US20050143418 Pesticidal heterocycles |
| 06/30/2005 | US20050143401 Anticancer agents; (4-(3-Fluorobenzyloxy)-3-chlorophenyl)-(6-(2-((2-methanesulphonyl-ethylamino)ethyl)-thiazol-4-yl)-quinazolin-4-yl)-amine |
| 06/30/2005 | US20050143397 Processes for preparation of ziprasidone |
| 06/30/2005 | US20050143396 Novel crystalline forms of ziprasidone hydrochloride |
| 06/30/2005 | US20050143390 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis |
| 06/30/2005 | US20050143387 Preserving cosmetic, household or technical products, use in paper treatment liquors, printing thickeners, printing thickeners of starch or cellulose derivatives and paints |
| 06/30/2005 | US20050143384 N-[5-(3,5-Dichloro-2-hydroxy-phenyl)-[1,3,4]thiadiazol-2-yl]-terephthalamic acid; thromboembolic disorder: infarction, ischemia, stroke, atherosclerosis, thrombophlebitis, embolism; mixture with second PAI-1 or factor Xa inhibitors, anti-coagulant, anti-platelet, thrombolytic, and fibrinolytic agents |
| 06/30/2005 | US20050143376 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones |
| 06/30/2005 | US20050143373 Benzodioxole derivatives |
| 06/30/2005 | US20050143372 Compounds, pharmaceutical compositions and methods of use therefor |
| 06/30/2005 | US20050143369 Gamma-secretase inhibitors |
| 06/30/2005 | US20050143368 Chemical compounds |
| 06/30/2005 | US20050143355 Pharmaceutically active salts and esters of 1-dimethylamino-3-(3-methoxyphenyl)-2-methylpentan-3-ol and 3- (3-dimethylamino-1-ethyl-1-hydroxy-2-methylpropyl)-phenol and methods of using same |
| 06/30/2005 | US20050143316 Hepatitis C virus inhibitors |
| 06/30/2005 | US20050139814 Benzofuran and benzothiophene derivatives useful in the treatmint of hyper-proliferative disorders |
| 06/30/2005 | DE10355223A1 Neue Makrocyclen zur Behandlung von Krebserkrankungen New macrocycles for the treatment of cancer |
| 06/30/2005 | CA2551944A1 2, 6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists |
| 06/30/2005 | CA2550012A1 Urea derivative, process for producing the same and use |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2549167A1 Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 06/30/2005 | CA2549098A1 Hiv protease inhibiting compounds |
| 06/30/2005 | CA2548393A1 Chemokine receptor binding compounds |
| 06/30/2005 | CA2548388A1 Heterocyclic aspartyl protease inhibitors |